Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neurocrine Biosciences Inc (NBIX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neurocrine Biosciences Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 914475.
Total stock buying since 2015: $0.
Total stock sales since 2015: $553,389,273.
Total stock option exercises since 2015: $112,361,564.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 381,272 | $52,092,153 | 413,767 | $15,477,653 |
| 2024 | 0 | $0 | 767,118 | $104,902,106 | 734,237 | $33,104,501 |
| 2023 | 0 | $0 | 602,981 | $67,979,111 | 314,830 | $12,705,238 |
| 2022 | 0 | $0 | 339,724 | $35,585,341 | 275,903 | $8,378,407 |
| 2021 | 0 | $0 | 470,442 | $52,030,343 | 373,591 | $5,060,074 |
| 2020 | 0 | $0 | 352,778 | $38,556,859 | 168,347 | $8,930,685 |
| 2019 | 0 | $0 | 506,699 | $45,323,842 | 438,362 | $9,802,547 |
| 2018 | 0 | $0 | 801,747 | $73,265,316 | 852,782 | $10,193,425 |
| 2017 | 0 | $0 | 675,618 | $38,755,247 | 649,073 | $4,790,919 |
| 2016 | 0 | $0 | 204,895 | $9,503,074 | 139,870 | $648,814 |
| 2015 | 0 | $0 | 868,262 | $35,395,881 | 715,887 | $3,269,301 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 80,638 | $10,515,129 | 80,638 | $6,830,649 |
| 2025-05 | 0 | $0 | 39,613 | $4,463,152 | 55,119 | $1,682,651 |
| 2025-02 | 0 | $0 | 43,733 | $5,134,369 | 56,730 | $0 |
| 2025-01 | 0 | $0 | 217,288 | $31,979,503 | 221,280 | $6,964,353 |
| 2024-12 | 0 | $0 | 1,363 | $184,848 | 1,363 | $107,703 |
| 2024-11 | 0 | $0 | 2,331 | $294,372 | 11,771 | $625,757 |
| 2024-10 | 0 | $0 | 1,295 | $147,189 | 0 | $0 |
| 2024-09 | 0 | $0 | 3,461 | $421,826 | 0 | $0 |
| 2024-08 | 0 | $0 | 62,964 | $9,461,095 | 44,614 | $2,886,728 |
| 2024-07 | 0 | $0 | 22,863 | $3,328,303 | 21,963 | $1,557,381 |
| 2024-05 | 0 | $0 | 86,252 | $11,702,771 | 101,943 | $4,598,644 |
| 2024-04 | 0 | $0 | 19,818 | $2,643,027 | 19,818 | $1,610,608 |
| 2024-03 | 0 | $0 | 150,000 | $20,963,646 | 150,000 | $9,710,925 |
| 2024-02 | 0 | $0 | 139,040 | $18,768,960 | 109,907 | $6,199,368 |
| 2024-01 | 0 | $0 | 277,731 | $36,986,069 | 272,858 | $5,807,387 |
| 2023-12 | 0 | $0 | 169,830 | $20,763,089 | 149,830 | $10,593,239 |
| 2023-11 | 0 | $0 | 13,250 | $1,490,642 | 0 | $0 |
| 2023-10 | 0 | $0 | 1,437 | $161,921 | 0 | $0 |
| 2023-09 | 0 | $0 | 10,824 | $1,216,841 | 10,000 | $129,800 |
| 2023-08 | 0 | $0 | 33,020 | $3,546,809 | 0 | $0 |
| 2023-05 | 0 | $0 | 15,697 | $1,620,181 | 7,625 | $96,913 |
| 2023-04 | 0 | $0 | 21,437 | $2,229,041 | 12,375 | $157,286 |
| 2023-02 | 0 | $0 | 189,229 | $19,432,543 | 0 | $0 |
| 2023-01 | 0 | $0 | 148,257 | $17,518,044 | 135,000 | $1,728,000 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-10 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 457 | 135.00 | 61,695 |
| 2025-07-10 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 457 | 79.02 | 36,112 |
| 2025-07-09 | Onyia Jude (Chief Scientific Officer) | Sale | 59,819 | 130.46 | 7,803,687 |
| 2025-07-09 | Onyia Jude (Chief Scientific Officer) | Option Ex | 59,819 | 84.74 | 5,069,062 |
| 2025-07-02 | Onyia Jude (Chief Scientific Officer) | Sale | 20,362 | 130.13 | 2,649,747 |
| 2025-07-02 | Onyia Jude (Chief Scientific Officer) | Option Ex | 20,362 | 84.74 | 1,725,475 |
| 2025-05-27 | Gorman Kevin Charles (Director) | Sale | 9,613 | 120.38 | 1,157,212 |
| 2025-05-22 | Mercier Johanna (Director) | Option Ex | 1,435 | .00 | 0 |
| 2025-05-22 | Norwalk Leslie V (Director) | Option Ex | 1,435 | .00 | 0 |
| 2025-05-22 | Sharp Shalini (Director) | Option Ex | 1,435 | .00 | 0 |
| 2025-05-22 | Rastetter William H (Director) | Option Ex | 2,869 | .00 | 0 |
| 2025-05-22 | Poon Christine A (Director) | Option Ex | 1,435 | .00 | 0 |
| 2025-05-22 | Pops Richard F (Director) | Option Ex | 2,869 | .00 | 0 |
| 2025-05-22 | Lyons Gary A (Director) | Option Ex | 1,435 | .00 | 0 |
| 2025-05-22 | Sherwin Stephen A (Director) | Option Ex | 2,869 | .00 | 0 |
| 2025-05-22 | Morrow George J (Director) | Option Ex | 2,869 | .00 | 0 |
| 2025-05-16 | Cooke Julie (Chief Human Resources Officer) | Option Ex | 6,468 | 61.82 | 399,851 |
| 2025-05-05 | Rastetter William H (Director) | Sale | 30,000 | 110.20 | 3,305,940 |
| 2025-05-05 | Rastetter William H (Director) | Option Ex | 30,000 | 42.76 | 1,282,800 |
| 2025-02-14 | Roberts Eiry (Chief Medical Officer) | Sale | 500 | 115.04 | 57,521 |
| 2025-02-13 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 1,471 | 116.70 | 171,673 |
| 2025-02-13 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 2,759 | .00 | 0 |
| 2025-02-13 | Boyer David W. (Chief Corp. Affairs Officer) | Sale | 1,785 | 116.74 | 208,380 |
| 2025-02-13 | Boyer David W. (Chief Corp. Affairs Officer) | Option Ex | 3,352 | .00 | 0 |
| 2025-02-13 | Onyia Jude (Chief Scientific Officer) | Sale | 2,879 | 116.79 | 336,238 |
| 2025-02-13 | Onyia Jude (Chief Scientific Officer) | Option Ex | 5,407 | .00 | 0 |
| 2025-02-13 | Cooke Julie (Chief Human Resources Officer) | Sale | 1,551 | 116.78 | 181,130 |
| 2025-02-13 | Cooke Julie (Chief Human Resources Officer) | Option Ex | 2,910 | .00 | 0 |
| 2025-02-13 | Roberts Eiry (Chief Medical Officer) | Sale | 1,718 | 116.82 | 200,700 |
| 2025-02-13 | Roberts Eiry (Chief Medical Officer) | Option Ex | 4,605 | .00 | 0 |
| 2025-02-13 | Abernethy Matt (Chief Financial Officer) | Sale | 2,558 | 116.86 | 298,925 |
| 2025-02-13 | Abernethy Matt (Chief Financial Officer) | Option Ex | 4,807 | .00 | 0 |
| 2025-02-13 | Gano Kyle (Chief Executive Officer) | Sale | 2,558 | 116.85 | 298,909 |
| 2025-02-13 | Gano Kyle (Chief Executive Officer) | Option Ex | 4,807 | .00 | 0 |
| 2025-02-13 | Lippoldt Darin (Chief Legal Officer) | Sale | 2,184 | 116.75 | 254,992 |
| 2025-02-13 | Lippoldt Darin (Chief Legal Officer) | Option Ex | 4,100 | .00 | 0 |
| 2025-02-13 | Gorman Kevin Charles (Director) | Sale | 5,844 | 116.69 | 681,912 |
| 2025-02-13 | Gorman Kevin Charles (Director) | Option Ex | 10,979 | .00 | 0 |
| 2025-02-13 | Sherwin Stephen A (Director) | Sale | 13,831 | 116.69 | 1,613,925 |
| 2025-02-10 | Boyer David W. (Chief Corp. Affairs Officer) | Sale | 700 | 118.31 | 82,819 |
| 2025-02-10 | Cooke Julie (Chief Human Resources Officer) | Sale | 700 | 118.28 | 82,792 |
| 2025-02-10 | Roberts Eiry (Chief Medical Officer) | Sale | 980 | 118.22 | 115,852 |
| 2025-02-10 | Abernethy Matt (Chief Financial Officer) | Sale | 980 | 118.27 | 115,908 |
| 2025-02-10 | Benevich Eric (Chief Commercial Officer) | Sale | 980 | 118.31 | 115,940 |
| 2025-02-10 | Gano Kyle (Chief Executive Officer) | Sale | 980 | 118.39 | 116,020 |
| 2025-02-10 | Lippoldt Darin (Chief Legal Officer) | Sale | 911 | 118.25 | 107,726 |
| 2025-02-08 | Boyer David W. (Chief Corp. Affairs Officer) | Option Ex | 1,329 | .00 | 0 |
| 2025-02-08 | Cooke Julie (Chief Human Resources Officer) | Option Ex | 1,329 | .00 | 0 |
| 2025-02-08 | Roberts Eiry (Chief Medical Officer) | Option Ex | 1,860 | .00 | 0 |
| 2025-02-08 | Abernethy Matt (Chief Financial Officer) | Option Ex | 1,860 | .00 | 0 |
| 2025-02-08 | Benevich Eric (Chief Commercial Officer) | Option Ex | 1,860 | .00 | 0 |
| 2025-02-08 | Gano Kyle (Chief Executive Officer) | Option Ex | 1,860 | .00 | 0 |
| 2025-02-08 | Lippoldt Darin (Chief Legal Officer) | Option Ex | 1,727 | .00 | 0 |
| 2025-02-03 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 623 | 149.29 | 93,007 |
| 2025-02-03 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 1,179 | .00 | 0 |
| 2025-01-31 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 422 | 153.05 | 64,586 |
| 2025-01-31 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 801 | .00 | 0 |
| 2025-01-31 | Boyer David W. (Chief Corp. Affairs Officer) | Sale | 1,104 | 152.94 | 168,849 |
| 2025-01-31 | Boyer David W. (Chief Corp. Affairs Officer) | Option Ex | 2,096 | .00 | 0 |
| 2025-01-31 | Onyia Jude (Chief Scientific Officer) | Sale | 126 | 152.97 | 19,273 |
| 2025-01-31 | Onyia Jude (Chief Scientific Officer) | Option Ex | 238 | .00 | 0 |
| 2025-01-31 | Cooke Julie (Chief Human Resources Officer) | Sale | 1,740 | 152.89 | 266,025 |
| 2025-01-31 | Cooke Julie (Chief Human Resources Officer) | Option Ex | 1,740 | .00 | 0 |
| 2025-01-31 | Gano Kyle (Chief Executive Officer) | Sale | 1,541 | 152.87 | 235,577 |
| 2025-01-31 | Gano Kyle (Chief Executive Officer) | Option Ex | 2,927 | .00 | 0 |
| 2025-01-31 | Lippoldt Darin (Chief Legal Officer) | Sale | 1,250 | 152.91 | 191,132 |
| 2025-01-31 | Lippoldt Darin (Chief Legal Officer) | Option Ex | 2,373 | .00 | 0 |
| 2025-01-27 | Gorman Kevin Charles (Director) | Sale | 146,105 | 149.46 | 21,836,561 |
| 2025-01-27 | Gorman Kevin Charles (Director) | Option Ex | 146,105 | 32.99 | 4,820,003 |
| 2025-01-15 | Gano Kyle (Chief Executive Officer) | Sale | 65,000 | 141.50 | 9,197,500 |
| 2025-01-15 | Gano Kyle (Chief Executive Officer) | Option Ex | 65,000 | 32.99 | 2,144,350 |
| 2024-12-31 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 272 | 138.10 | 37,563 |
| 2024-12-31 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 272 | 79.02 | 21,493 |
| 2024-12-17 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 1,091 | 135.00 | 147,285 |
| 2024-12-17 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 1,091 | 79.02 | 86,210 |
| 2024-11-29 | Onyia Jude (Chief Scientific Officer) | Sale | 2,331 | 126.29 | 294,372 |
| 2024-11-29 | Onyia Jude (Chief Scientific Officer) | Option Ex | 4,426 | .00 | 0 |
| 2024-11-08 | Roberts Eiry (Chief Medical Officer) | Option Ex | 7,345 | 85.19 | 625,757 |
| 2024-10-03 | Boyer David W. (Chief Corp. Affairs Officer) | Sale | 1,295 | 113.66 | 147,189 |
| 2024-09-13 | Boyer David W. (Chief Corp. Affairs Officer) | Sale | 3,461 | 121.88 | 421,826 |
| 2024-08-15 | Rastetter William H (Director) | Sale | 14,250 | 146.69 | 2,090,332 |
| 2024-08-13 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 7,143 | 150.11 | 1,072,207 |
| 2024-08-13 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 3,043 | 103.52 | 315,011 |
| 2024-08-13 | Abernethy Matt (Chief Financial Officer) | Sale | 14,100 | 150.38 | 2,120,343 |
| 2024-08-13 | Abernethy Matt (Chief Financial Officer) | Option Ex | 14,100 | 73.60 | 1,037,759 |
| 2024-08-13 | Lyons Gary A (Director) | Sale | 11,570 | 150.43 | 1,740,451 |
| 2024-08-13 | Lyons Gary A (Director) | Option Ex | 11,570 | 42.76 | 494,733 |
| 2024-08-06 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 273 | 147.70 | 40,322 |
| 2024-08-06 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 273 | 79.02 | 21,572 |
| 2024-08-01 | Cooke Julie (Chief Human Resources Officer) | Sale | 12,632 | 153.26 | 1,936,018 |
| 2024-08-01 | Cooke Julie (Chief Human Resources Officer) | Option Ex | 12,632 | 61.82 | 780,910 |
| 2024-08-01 | Lippoldt Darin (Chief Legal Officer) | Sale | 2,996 | 154.01 | 461,422 |
| 2024-08-01 | Lippoldt Darin (Chief Legal Officer) | Option Ex | 2,996 | 79.02 | 236,743 |
| 2024-07-16 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 2,857 | 150.05 | 428,684 |
| 2024-07-16 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 1,957 | 103.52 | 202,588 |
| 2024-07-16 | Cooke Julie (Chief Human Resources Officer) | Sale | 900 | 150.04 | 135,036 |
| 2024-07-16 | Cooke Julie (Chief Human Resources Officer) | Option Ex | 900 | 61.82 | 55,638 |
| 2024-07-16 | Abernethy Matt (Chief Financial Officer) | Sale | 900 | 150.04 | 135,036 |
| 2024-07-16 | Abernethy Matt (Chief Financial Officer) | Option Ex | 900 | 73.60 | 66,240 |
| 2024-07-16 | Lippoldt Darin (Chief Legal Officer) | Sale | 7,004 | 150.00 | 1,050,592 |
| 2024-07-16 | Lippoldt Darin (Chief Legal Officer) | Option Ex | 7,004 | 79.02 | 553,456 |
| 2024-07-16 | Lyons Gary A (Director) | Sale | 930 | 150.03 | 139,530 |
| 2024-07-16 | Lyons Gary A (Director) | Option Ex | 930 | 42.76 | 39,766 |
| 2024-07-01 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 272 | 138.11 | 37,565 |
| 2024-07-01 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 272 | 79.02 | 21,493 |
| 2024-07-01 | Cooke Julie (Chief Human Resources Officer) | Sale | 10,000 | 140.19 | 1,401,860 |
| 2024-07-01 | Cooke Julie (Chief Human Resources Officer) | Option Ex | 10,000 | 61.82 | 618,200 |
| 2024-05-31 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 273 | 136.55 | 37,278 |
| 2024-05-31 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 273 | 79.02 | 21,572 |
| 2024-05-29 | Sherwin Stephen A (Director) | Sale | 40,000 | 133.47 | 5,338,600 |
| 2024-05-29 | Sherwin Stephen A (Director) | Option Ex | 40,000 | 45.33 | 1,813,000 |
| 2024-05-17 | Mercier Johanna (Director) | Option Ex | 2,100 | .00 | 0 |
| 2024-05-17 | Norwalk Leslie V (Director) | Sale | 1,106 | 141.82 | 156,849 |
| 2024-05-17 | Norwalk Leslie V (Director) | Option Ex | 2,100 | .00 | 0 |
| 2024-05-17 | Pops Richard F (Director) | Sale | 2,100 | 141.84 | 297,859 |
| 2024-05-17 | Pops Richard F (Director) | Option Ex | 4,199 | .00 | 0 |
| 2024-05-17 | Lyons Gary A (Director) | Option Ex | 2,100 | .00 | 0 |
| 2024-05-17 | Sherwin Stephen A (Director) | Option Ex | 4,199 | .00 | 0 |
| 2024-05-17 | Morrow George J (Director) | Option Ex | 4,199 | .00 | 0 |
| 2024-05-15 | Abernethy Matt (Chief Financial Officer) | Sale | 15,000 | 140.24 | 2,103,615 |
| 2024-05-15 | Abernethy Matt (Chief Financial Officer) | Option Ex | 15,000 | 73.60 | 1,104,000 |
| 2024-05-14 | Abernethy Matt (Chief Financial Officer) | Sale | 15,000 | 135.66 | 2,034,825 |
| 2024-05-14 | Abernethy Matt (Chief Financial Officer) | Option Ex | 15,000 | 73.60 | 1,104,000 |
| 2024-05-14 | Lyons Gary A (Director) | Sale | 12,500 | 135.63 | 1,695,375 |
| 2024-05-14 | Lyons Gary A (Director) | Option Ex | 12,500 | 42.76 | 534,500 |
| 2024-05-06 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 273 | 140.55 | 38,370 |
| 2024-05-06 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 273 | 79.02 | 21,572 |
| 2024-04-15 | Benevich Eric (Chief Commercial Officer) | Sale | 19,818 | 133.37 | 2,643,027 |
| 2024-04-15 | Benevich Eric (Chief Commercial Officer) | Option Ex | 19,818 | 81.27 | 1,610,608 |
| 2024-03-21 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 5,000 | 145.06 | 725,320 |
| 2024-03-21 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 5,000 | 103.52 | 517,600 |
| 2024-03-14 | Benevich Eric (Chief Commercial Officer) | Sale | 75,000 | 139.38 | 10,453,425 |
| 2024-03-14 | Benevich Eric (Chief Commercial Officer) | Option Ex | 75,000 | 80.03 | 6,002,625 |
| 2024-03-14 | Morrow George J (Director) | Sale | 40,000 | 139.42 | 5,576,720 |
| 2024-03-14 | Morrow George J (Director) | Option Ex | 40,000 | 39.79 | 1,591,600 |
| 2024-03-13 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 3,000 | 140.14 | 420,419 |
| 2024-03-13 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 3,000 | 106.02 | 318,060 |
| 2024-03-13 | Pops Richard F (Director) | Sale | 23,200 | 140.33 | 3,255,632 |
| 2024-03-13 | Pops Richard F (Director) | Option Ex | 23,200 | 42.76 | 992,032 |
| 2024-03-11 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 200 | 140.00 | 28,000 |
| 2024-03-11 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 200 | 106.02 | 21,204 |
| 2024-03-11 | Pops Richard F (Director) | Sale | 100 | 140.00 | 14,000 |
| 2024-03-11 | Pops Richard F (Director) | Option Ex | 100 | 42.76 | 4,276 |
| 2024-03-08 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 1,800 | 140.03 | 252,052 |
| 2024-03-08 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 1,800 | 106.02 | 190,836 |
| 2024-03-08 | Pops Richard F (Director) | Sale | 1,700 | 140.05 | 238,078 |
| 2024-03-08 | Pops Richard F (Director) | Option Ex | 1,700 | 42.76 | 72,692 |
| 2024-02-29 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 273 | 135.51 | 36,994 |
| 2024-02-29 | Delaet Ingrid (Chief Regulatory Officer) | Option Ex | 273 | 79.02 | 21,572 |
| 2024-02-28 | Delaet Ingrid (Chief Regulatory Officer) | Sale | 6,544 | 135.42 | 886,188 |
Insider trading activities including stock purchases, stock sales, and option exercises of NBIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neurocrine Biosciences Inc (symbol NBIX, CIK number 914475) see the Securities and Exchange Commission (SEC) website.